Research ArticleBasic Science Investigation
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively and Flavia Pichiorri
Journal of Nuclear Medicine June 2021, 62 (6) 795-801; DOI: https://doi.org/10.2967/jnumed.120.251983
Megan Minnix
1Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California
2Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope, Duarte, California
Vikram Adhikarla
3Department of Computational and Quantitative Medicine, Division of Mathematical Oncology, Beckman Research Institute, City of Hope, Duarte, California
Enrico Caserta
4Briskin Myeloma Center and Department of Hematologic Malignancies Research Institute, City of Hope, Duarte, California; and
Erasmus Poku
5Radiopharmacy, City of Hope, Duarte, California
Russell Rockne
3Department of Computational and Quantitative Medicine, Division of Mathematical Oncology, Beckman Research Institute, City of Hope, Duarte, California
John E. Shively
1Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California
Flavia Pichiorri
4Briskin Myeloma Center and Department of Hematologic Malignancies Research Institute, City of Hope, Duarte, California; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 6
June 1, 2021
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively, Flavia Pichiorri
Journal of Nuclear Medicine Jun 2021, 62 (6) 795-801; DOI: 10.2967/jnumed.120.251983
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively, Flavia Pichiorri
Journal of Nuclear Medicine Jun 2021, 62 (6) 795-801; DOI: 10.2967/jnumed.120.251983
Jump to section
Related Articles
Cited By...
- Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers
- Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
- Improved Tumor Responses with Sequential Targeted {alpha}-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice